Related references
Note: Only part of the references are listed.C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
W. Reinisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
Matthias Jurgens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Clinical Features and Risk Factors for Primary Surgery in 205 Patients With Crohn's Disease: Analysis of a South China Cohort
Xin-ming Song et al.
DISEASES OF THE COLON & RECTUM (2011)
Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn's disease
Takayuki Yamamoto et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Quality of life of patients and medical cost of half elemental diet as maintenance therapy for Crohn's disease: Secondary outcomes of a randomised controlled trial
S. Takagi et al.
DIGESTIVE AND LIVER DISEASE (2009)
Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro
Claudia Guzy et al.
EUROPEAN JOURNAL OF NUTRITION (2009)
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
F. Schnitzler et al.
GUT (2009)
Effects of Light Smoking Consumption on the Clinical Course of Crohn's Disease
Philippe Seksik et al.
INFLAMMATORY BOWEL DISEASES (2009)
Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update
Ann Corken Mackey et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease
S. T. Leach et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: A prospective study
Takayuki Yamamoto et al.
INFLAMMATORY BOWEL DISEASES (2007)
Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomized-controlled trial
S. Takagi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease
Elana A. Maser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Effect of concurrent elemental diet on infliximab treatment for Crohn's disease
Torao Tanaka et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
A simple biological score for predicting low risk of short-term relapse in Crohn's disease
Yann Consigny et al.
INFLAMMATORY BOWEL DISEASES (2006)
Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease
R. Berni Canani et al.
DIGESTIVE AND LIVER DISEASE (2006)
European evidence based consensus on the diagnosis and management of Crohn's disease:: current management
SPL Travis et al.
GUT (2006)
Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy
M Esaki et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Optimizing anti-TNF treatment in inflammatory bowel disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease
S Verma et al.
DIGESTIVE AND LIVER DISEASE (2000)
Share Paper
